Philips adds Respironics to Moore microprocessor patent license
Patriot Scientific Corporation (OTCBB: PTSC) has announced that Royal
Philips Electronics has purchased a Moore Microprocessor Patent (MMP)
Portfolio license from the TPL Group to cover its recently acquired
business unit, Respironics, a leader in the respiratory supplier market.
Royal Philips Electronics purchased its initial MMP license in 2007.
“We are pleased to see Royal Philips Electronics extend coverage to
its newly acquired business unit, expanding the wide range of companies,
and applications, licensed on the MMP Portfolio,” said Rick Goerner,
Patriot Scientific President and CEO.
The Moore Microprocessor Patent Portfolio contains intellectual
property that is jointly owned by the privately-held TPL Group and
publicly-held Patriot Scientific Corporation. The MMP Portfolio includes
seven US patents as well as their European and Japanese counterparts. It
is widely recognized that the MMP Portfolio protects fundamental
technology used in microprocessors, microcontrollers, digital signal
processors (DSPs), embedded processors and system-on-chip (SoC) devices.
Industry leaders including Hewlett Packard, Kenwood, Sony, Robert
Bosch, Philips, Nokia, DirecTV and Fujitsu are among the more than fifty
global companies from the US, Japan, Korea, Taiwan and Europe that have
purchased MMP Portfolio licenses.
Bookmark this page